SYNLAB and ALCEDIAG recently launched the first blood test to assist in mental health diagnosis in France. The test is aimed at differentiating bipolar disorders from depression. The news may be ...

Researchers have developed a quick and simple blood test that, combined with existing diagnostic tools, improved the diagnosis of bipolar disorder, a condition commonly misdiagnosed as major ...

Bipolar disorder (once known as manic depression) is a mental disorder that causes unusual changes in mood, concentration, and energy or activity levels, which may make everdayl tasks difficult.

Oct. 25 (UPI) --Researchers at the University of Cambridge said Wednesday they have developed a way to use biomarkers in a blood test to more accurately diagnose bipolar disorder. Details of the ...

In the not-too-distant future, psychiatrists might be able to diagnose neurodivergent disorders like ADHD and autism in as little as 15 minutes. Using only a high-definition motion sensor and an ...

Myriad Genetics, Inc. announced that a study published in the Journal of Clinical Psychopharmacology found that the GeneSight® Psychotropic Test significantly reduced psychiatric hospitalizations in ...

Psychology Today's online self-tests are intended for informational purposes only and are not diagnostic tools. Psychology Today does not capture or store personally identifiable information, and your ...

The first-ever DNA test to help determine if someone has a greater risk of developing opioid use disorder was approved by the Food and Drug Administration (FDA) this week. The FDA approved the ...

Please provide your email address to receive an email when new articles are posted on . AvertD is the first test approved by the FDA to evaluate an elevated risk for developing opioid use disorder.

Lizzie Duszynski-Goodman is a journalist living in the Midwest with her husband and two young children. Her work explores the intersection of mental health, wellness and parenting. She is the former ...